A fluorescence in situ hybridization‐based screen allows rapid detection of adverse cytogenetic alterations in patients with acute myeloid leukemia

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Genes, Chromosomes and Cancer

• Publication date

  2017-05-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/gcc.22466PMID 28420034
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treating acute myeloid leukemia in older adults.

  2014cited by this paper
• Cytogenetics of Acute Leukemia

  2013cited by this paper
• A novel hierarchical prognostic model of AML solely based on molecular mutations.

  2012cited by this paper
• TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome.

  2012cited by this paper
• Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

  2010cited by this paper
• The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia

  2009cited by this paper
• Rapid and sensitive screening for CEBPA mutations in acute myeloid leukaemia

  2008cited by this paper
• Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype.

  2008cited by this paper
• Chromosome aberrations, gene mutations and expression changes, and prognosis in adult acute myeloid leukemia.

  2006cited by this paper
• Strategies for the treatment of acute promyelocytic leukemia.

  2006influential reference
• Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype.

  2005cited by this paper
• Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.

  2005cited by this paper
• Frequency of fab subtypes in acute myeloid leukemia patients at Aga Khan University Hospital Karachi.

  2005cited by this paper
• Cytogenetics in acute leukemia.

  2004cited by this paper
• Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup.

  2004cited by this paper
• High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients.

  2003cited by this paper
• Relation of In Vitro Growth Characteristics to Cytogenetics and Treatment Outcome in Acute Myeloid Leukemia: Prognostic Significance in Patients with a Normal Karyotype

  2003cited by this paper
• Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461).

  2002cited by this paper
• Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease.

  2002cited by this paper
• The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia.

  2001cited by this paper
• Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study.

  2000cited by this paper
• Prognostic value of cytogenetic findings in adults with acute myeloid leukemia.

  2000cited by this paper
• Detection of monosomy 7 in bone marrow by fluorescence in situ hybridization. A study of Fanconi anemia patients and review of the literature.

  1999cited by this paper
• Discordant detection of monosomy 7 by GTG-banding and FISH in a patient with Shwachman-Diamond syndrome without evidence of myelodysplastic syndrome or acute myelogenous leukemia.

  1999cited by this paper
• Hidden monosomy 7 in acute myeloid leukemia and myelodysplastic syndrome detected by interphase fluorescence in situ hybridization.

  1996cited by this paper
• Fluorescence in situ hybridization improves the detection of monosomy 7 in myelodysplastic syndromes.

  1994cited by this paper
• Combination of classical and interphase cytogenetics to investigate the biology of myeloid disorders: detection of masked monosomy 7 in AML.

  1993cited by this paper
• Acute myeloid leukemia-FAB classification and its correlation with clinico-haematological features.

  1993cited by this paper

• No citing papers are available for this paper.